Shinde, S. et al. 2023. Overview on remogliflozin SGLT-2 inhibitor in the management of type-2 diabetic mellitus in human beings. Fundamental and Experimental Biology. 112, 4 (Dec. 2023), 156–167. DOI:https://doi.org/10.31489/2023bmg4/156-167.